-
UNDERSTANDING PRIORITIES IN HEALTH ECONOMICS: MAPPING COST-EFFECTIVENESS AND DISEASE BURDEN TRENDS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS WITH REAL-WORLD DATA REUSING BRAZILIAN HEALTH SYSTEM DATABASES: A CASE STUDY IN BREAST CANCER
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION & ASSOCIATED DRIVERS AMONG PATIENTS WITH OSTEOGENESIS IMPERFECTA
Mar 18, 2026, 21:38 PM -
THE PRICE OF FEAR: VALUING FEAR OF CONTAGION FOR VACCINE ECONOMIC APPRAISAL: A TARGETED REVIEW
Mar 18, 2026, 21:38 PM -
IDENTIFYING MEANINGFUL PATIENT SAVINGS ON GENERICS: DIRECT-TO-CONSUMER PRICES VS COMMERCIAL INSURANCE
Mar 18, 2026, 21:38 PM -
ESTIMATING THE HEALTH OPPORTUNITY COST OF PUBLIC HEALTH EXPENDITURE IN KAZAKHSTAN: EMPIRICAL SUPPLY-SIDE COST-EFFECTIVENESS THRESHOLDS
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ENDOMETRIAL CANCER TREATMENT IN THE PUBLIC SETTING IN BRAZIL
Mar 18, 2026, 21:38 PM -
MAPPING THE BURDEN AND MANAGEMENT OF ASTHMA, SEVERE ASTHMA, AND EOSINOPHILIC ASTHMA ACROSS ONTARIO, CANADA
Mar 18, 2026, 21:38 PM -
CATASTROPHIC HEALTH EXPENDITURE SUBSTANTIALLY UNDERESTIMATES FINANCIAL HARDSHIP IN HOUSEHOLDS WITH CHRONIC CONDITIONS
Mar 18, 2026, 21:38 PM -
EFFECT OF CHINESE HERBAL MEDICINE COMBINED WITH CONVENTIONAL ANTI-OSTEOPOROTIC MEDICATION ON FRACTURE RISK IN OLDER ADULTS WITH OSTEOPOROSIS: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF ALPHA BLOCKERS VERSUS ALPHA INHIBITORS USING PATIENT-REPORTED OUTCOMES AMONG ADULT MEN DIAGNOSED WITH BPH IN THE USA USING MEPS DATA (2018-2023)
Mar 18, 2026, 21:38 PM -
INCREASING UTILITY OF INTEGRATED REAL-WORLD EVIDENCE THROUGHOUT THE PRODUCT LIFECYCLE TO SUPPORT HEALTHCARE REIMBURSEMENT
Mar 18, 2026, 21:38 PM -
OPIOID USE DISORDER TREATMENT INITIATION AMONG DUAL-ELIGIBLE BENEFICIARIES USING LINKED MEDICARE AND MEDICAID CLAIMS
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF SGLT2I, GLP-1, AND METFORMIN ON CARDIOVASCULAR OUTCOMES IN ADULTS WITH SEVERE MENTAL ILLNESS
Mar 18, 2026, 21:38 PM -
A HOLISTIC EVALUATION OF ADVERSE EFFECTS ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) IN PROSTATE CANCER: AN ARTIFICIAL INTELLIGENCE ASSISTED TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
ROLE OF REAL-WORLD EVIDENCE IN SUPPORTING AND VALIDATING CROSSOVER ADJUSTMENTS OF OVERALL SURVIVAL IN ONCOLOGY TRIALS: A SYSTEMATIC LITERATURE REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS OF TREATMENTS FOR SELECTED TUMORS
Mar 18, 2026, 21:38 PM -
HEALTH-RELATED QUALITY OF LIFE AND EMOTION REGULATION STRATEGIES IN ADOLESCENTS WITH DEPRESSION IN CHINA: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
THE BUDGET IMPACT OF INTRODUCING ZONGERTINIB INTO THE FORMULARY FOR TREATMENT-NAÏVE AND PRETREATED HER2-MUTANT ADVANCED NSCLC IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND EVALUATION OF ERADICATION EFFICIENCY OF NOVEL GASTRORETENTIVE DRUG DELIVERY SYSTEM FOR THE TREATMENT OF H. PYLORIINFECTION
Mar 18, 2026, 21:38 PM -
ESTIMATING INDIRECT ECONOMIC COSTS OF OBESITY AMONG COLOMBIA’S WORKFORCE
Mar 18, 2026, 21:38 PM
